Fremanezumab

Category: Migraine / Tension Headache



Fremanezumab Overview

Fremanezumab (INN), marketed under the trade name Ajovy, is a humanized monoclonal antibody directed against calcitonin-related polypeptides (CGRP) alpha and beta.[1] It is used for the preventative treatment of migraine. Fremanezumab was discovered and developed by Rinat Neuroscience, was acquired by Pfizer in 2006, and was then licensed to Teva.[2] History In 2018 Teva stopped development of fremanezumab for the treatment of chronic cluster headache afte...

Read more Fremanezumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fremanezumab

Recent Fremanezumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fremanezumab
  • Injection: 150mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Fremanezumab or a similar ingredient: (1 result)

  • AJOVY Fremanezumab-vfrm



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA